India to Singapore: Thalidomide Export Trade Route
India has recorded 38 verified shipments of Thalidomide exported to Singapore, representing a combined trade value of $40.8K USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $1.1K USD. The leading Indian exporter is 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, which accounts for 46% of total export value with 16 shipments worth $18.8K USD. On the buying side, FOR THE ORDER OF is the largest importer in Singapore with $14.8K USD in purchases. The top 3 suppliers — 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED , GRAMEEN PHARMA LLP — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Singapore Thalidomide corridor is one of India's established pharmaceutical export routes, with 38 shipments documented worth a combined $40.8K USD. The route is dominated by 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's thalidomide manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $1.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (0%) and air (100%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October-December, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 13.1%, placing it at rank #10 among India's top thalidomide export destinations globally.
On the import side, key buyers of Indian thalidomide in Singapore include FOR THE ORDER OF, FOR THE ORDER OF , THE MANAGER and 13 others. FOR THE ORDER OF is the single largest importer with 13 shipments valued at $14.8K USD.
